Avego invests in private and public companies developing and commercializing innovative products and services for patients, practitioners, and other stakeholders across the healthcare continuum. This is self-described.

Avego

Patheon provides contract development and manufacturing organization (CDMO) services for drug development, clinical trial logistics, and commercial manufacturing.

Patheon

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Stryker Corporation

Zimmer Biomet is a global leader in musculoskeletal healthcare, specializing in the design, manufacture, and distribution of a comprehensive line of products for orthopaedic reconstructive surgery, sports medicine, biologics, extremities, and trauma. The company's portfolio includes joint reconstruction, bone and skeletal repair, sports medicine injections, soft tissue repair, and bone healing therapies.

Metric
Company Name	Avego	Patheon	Stryker Corporation	Zimmer Biomet
Symbol			SYK
MSH ID	COM:AVEGO	COM:PATHEON	COM:STRYKER	COM:ZIMMERBIOMET
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Financial Services & Finance	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Healthcare & Health Services	Pharmaceuticals	Medical - Devices	Medical Devices
Country	US	US	US	US
Stage
Employee Count			52K	17.64K
Website	avego.com	patheon.com	stryker.com	zimmerbiomet.com
LinkedIn	avego-management		stryker	zimmerbiomet
Founders

Metric
Market Cap		128.51B
Enterprise Value
Monthly Web Traffic	21.85K	1.16M
Web Traffic Growth	-0.29	0.10
Valuation
Raised Capital

Metric
Revenue			20.50B
Revenue (LTM)
Revenue (NTM)
Gross Profit			13.06B
EBITDA			4.95B
Operating Income			3.89B
Net Income			3.17B
EPS			8.34
Diluted EPS			8.25
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.64
Operating Profit Margin			0.20
EBITDA Margin			0.24
Net Profit Margin			0.16
Return on Equity			0.18
Return on Assets			0.09
Return on Capital Employed			0.13

AVEG

COM:AVEGO

Avego

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			41.17
P/B Ratio			3.27
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			6.62
EV Multiple			24.94

Metric
Days Sales Outstanding			67.04
Days Payables Outstanding
Days Inventory Outstanding			241.76
Operating Cycle			304.64
Cash Conversion Cycle			302.23
Asset Turnover			0.55

Metric
Operating Cash Flow			3.71B
Free Cash Flow			3.14B
Cash Flow to Debt			0.34
Operating Cash Flow/Sales			0.18
Free Cash Flow Yield			0.02

Metric
Cash & Equivalents			2.97B
Accounts Receivable			-175M
Inventory			4.84B
Goodwill			15.24B
Debt to Capitalization			0.51
Debt to Assets			0.27
Current Ratio			1.58
Quick Ratio			0.99

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.00
R&D to Revenue			0.07
SG&A to Revenue